drugset / Trial / NCT02185417

Diuretic Comparison Project

NCT02185417

Phase 3 Completed 20723 enrolled VA Office of Research and Development
RandomizedParallel-groupOpen-labelTreatment

Summary

The Diuretic Comparison Project aimed to evaluate whether chlorthalidone, as compared with hydrochlorothiazide, would reduce the risk of major nonfatal cardiovascular disease outcomes and non-cancer-related deaths in older patients with hypertension who were receiving hydrochlorothiazide at baseline. The investigators incorporated the pragmatic methods used by the Department of Veterans Affairs (VA) Healthcare System to provide a real-world assessment of the effectiveness of chlorthalidone as compared with hydrochlorothiazide in routine clinical care.

Timeline

Start
2016-06-15
Primary completion
2022-10-15
Completion
2022-12-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorthalidone Other / unclassified 12.5 mg
Comparator Chlorthalidone Other / unclassified 25 mg
Comparator Hydrochlorothiazide Unknown 25 mg
Comparator Hydrochlorothiazide Unknown 50 mg

Indications